查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092759

藥物發現技術市場：依藥物類型、技術、應用、最終用途、國家及地區分類－產業分析、市場規模、市場佔有率及2026年至2033年預測

Drug Discovery Technologies Market, By Drug Type, By Technology, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 430 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，藥物發現技術市場價值將達到 435.061 億美元，並預計從 2026 年到 2033 年將以 11.3% 的複合年成長率成長。

藥物發現技術是指用於識別和開發有前景的新藥的科學方法、數位技術和研究平台。這些技術對藥物開發平臺至關重要，能夠幫助科學家識別與疾病相關的生物標的、篩檢龐大的化合物庫，並最佳化有前景的藥物以進行後續測試。這些技術也有助於闡明疾病機制和評估藥物療效等關鍵活動。

藥物研發技術市場—市場動態

癌症和神經系統疾病治療需求的不斷成長，以及基因組學領域的快速發展，預計將推動市場需求。

製藥和生技公司正致力於快速且有效率地將新療法推向市場，從而推動藥物發現技術市場的強勁成長。癌症、神經系統疾病、自體免疫疾病和罕見遺傳疾病等慢性複雜疾病負擔日益加重，促使人們對創新藥物發現方法的需求不斷成長。傳統的藥物發現方法通常耗時、成本高且風險龐大，因此各機構紛紛採用更先進的數據驅動型技術。現代藥物發現平台能夠幫助研究人員識別生物標的、篩檢有前景的化合物，並快速且準確地最佳化候選藥物。精準醫療和個人化醫療的日益普及也推動了先進藥物發現工具的應用。

基因組學——一個加深我們對影響疾病發生和治療反應的遺傳因素理解的領域——的快速發展需求正在推動藥物發現技術市場的成長。基因組學也正在加速「精準醫療」的趨勢，精準醫療的核心在於個人化治療。醫療專業人員和製藥公司對個人化醫療日益成長的興趣，以及對能夠分析基因組數據的先進藥物發現平台的需求不斷增加，共同推動了市場成長。因此，製藥和生物技術公司正加大對能夠分析和解讀複雜遺傳資訊以識別新型治療標靶的技術的投資。大規模基因組資料庫和生物資訊工具的出現，為數據驅動的藥物發現開闢了新的途徑。基因組學在腫瘤學、罕見疾病和遺傳性疾病等領域尤其重要，因為了解遺傳機制對於開發治療方法至關重要。此外，基因組學研究也增加了對先進藥物發現技術的需求，推動了藥物發現技術市場的成長。

藥物發現技術市場－市場區隔分析：

全球藥物發現技術市場按藥物類型、技術、應用、最終用途和地區進行細分。

根據藥物類型，市場可分為六大類：生物製藥、小分子藥物、細胞和基因療法、疫苗、蛋白質和胜肽類藥物以及其他藥物。小分子藥物在各類藥物的銷售額中佔較大佔有率。藥物發現技術對於小分子藥物的研發至關重要，它支持標靶檢驗、化合物篩檢、分子建模、合理藥物設計和候選化合物最佳化等重要功能。製藥公司持續投入大量研發資金用於小分子藥物項目，原因多種多樣，包括已證實的療效、成熟的研發流程以及給藥方便等。

藥物發現技術市場—區域分析

在亞太地區，中國、印度、韓國和日本等國家正大力投資，以增強其藥物研發和生物技術能力。不斷擴大的研究基礎設施、增加的醫療保健支出以及臨床和轉化研究項目的增加，正在推動先進藥物發現技術的應用。龐大的病患群體、不斷壯大的科研團隊以及政府促進生命科學創新的舉措，都在推動國內外企業加大研發投入。

在拉丁美洲、中東和非洲地區，隨著醫療保健體系的演進和科學研究能力的不斷提升，市場也穩步發展。此外，生物醫學研究資金籌措的增加、對醫療創新日益成長的關注以及國際科研合作的不斷拓展，都推動了對藥物研發技術的需求。

目錄

第1章：藥物發現技術市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：藥物發現技術的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：藥物發現技術產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：藥物研發技術市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：藥物發現技術的市場趨勢

  • 藥物研發技術市佔率分析（2025年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 藥物發現技術市場：依藥物類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按藥物類型
    • 生物製劑
    • 小分子藥物
    • 細胞和基因治療
    • 疫苗
    • 蛋白質和胜肽類藥物
    • 其他

第8章 藥物發現技術市場：依技術分類

  • 概述
    • 基於細分市場的市場佔有率分析：按技術分類
    • 高通量篩檢（HTS）
    • 基因組學和蛋白​​質組學技術
    • 組合化學
    • 電腦輔助藥物發現
    • 藥物基因體學
    • 其他

第9章 藥物發現技術市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 神經病學
    • 心血管疾病
    • 感染疾病
    • 免疫學與自體免疫疾病
    • 腫瘤學
    • 其他

第10章 藥物發現技術市場：依最終用途分類

  • 概述
    • 按最終用途分類的市佔率分析。
    • 製藥和生物技術公司
    • 受託研究機構（CRO）
    • 學術研究
    • 其他

第11章 藥物發現技術市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他中東和非洲國家

第12章：主要供應商分析：藥物發現技術產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Thermo Fisher Scientific
    • Danaher Corporation
    • Agilent Technologies
    • PerkinElmer
    • Bio-Rad Laboratories
    • Illumina
    • Waters Corporation
    • Bruker Corporation
    • Charles River Laboratories
    • Evotec SE
    • Schrodinger
    • Certara
    • IQVIA
    • Benchling
    • Recursion Pharmaceuticals
    • Owkin
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6884

Drug Discovery Technologies Market size was valued at USD 43,506.1 Million in 2025, expanding to a CAGR of 11.3% from 2026 to 2033.

Drug discovery technologies are the scientific methods, digital technologies and research platforms used to identify and develop potential new medicines. They are essential in the drug development pipeline where they help scientists find biological targets associated with diseases, screen large libraries of compounds and optimize potential drugs for further testing. These technologies facilitate key activities like understanding disease mechanisms, evaluating drug effectiveness etc.

Drug Discovery Technologies Market- Market Dynamics

Rising demand for treatment of disease such as cancer, neurological disorders and rapid developments in genomics are expected to propel market demand

Pharmaceutical and biotechnology companies are striving to bring new treatments to market faster and more efficiently, which is driving the solid growth of the drug discovery technologies market. Increasing burden of chronic and complex diseases such as cancer, neurological disorders, autoimmune diseases and rare genetic diseases is resulting in increased demand for innovative approaches to drug discovery. Traditional drug discovery methods are usually time-consuming, expensive, and associated with high development risks, prompting organizations to adopt more advanced and data-driven technologies. Modern discovery platforms help researchers identify biological targets, screen potential compounds, and optimize drug candidates with greater speed and accuracy. Also, the growing focus on precision medicine and patient-specific treatments is encouraging wider adoption of sophisticated discovery tools.

The demand for genomics that is fast changing and provides a better understanding of the genetic factors that influence disease development and response to treatment is supplementing the growth of the drug discovery technologies market. Genomics is also accelerating the trend toward precision medicine, where treatments are made for personalized therapies. Growing interest in personalized therapies among healthcare providers and pharmaceutical companies to meet the rising demand for advanced drug discovery platforms that can analyze genomic data is fueling the market. Consequently, pharmaceutical and biotechnology companies are investing more and more in technologies that can analyze and interpret complex genetic information to identify novel therapeutic targets. The availability of large-scale genomic databases and bioinformatics tools has opened up new avenues for data-driven drug discovery. Genomics is predominantly valuable in areas such as oncology, rare diseases, and inherited disorders, where understanding genetic mechanisms is critical for treatment development. In addition, genomic research is increasing the need for sophisticated drug discovery technologies, boosting drug discovery technologies market growth.

Drug Discovery Technologies Market- Segmentation Analysis:

The Global Drug Discovery Technologies Market is segmented on the basis of Drug Type, Technology, Application, End-Use, and Region.

The market is divided into six categories based on Drug Type: biologics, small molecule drugs, cell & gene therapies, vaccines, protein & peptide drugs, and others. The small molecule drugs segment represented a substantial revenue share in the drug type. Drug discovery technologies are critical for the development of small molecule drugs and support important functions such as target validation, compound screening, molecular modelling, rational drug design and candidate optimization. Pharma companies continue to spend a lot of research dollars on small molecule programs for multiple reasons including their proven therapeutic effectiveness, well-established development pathways, ease of administration, etc.

Drug Discovery Technologies Market- Geographical Insights

In Asia-Pacific region, countries including China, India, South Korea, and Japan are making substantial investments in pharmaceutical research and biotechnology capabilities. The adoption of advanced drug discovery technologies is being supported by expanding research infrastructure, increased healthcare spending, and an increasing number of clinical and translational research programs. A large patient population and a growing scientific talent pool, combined with government initiatives to promote life sciences innovation, are increasing research by domestic and international companies.

In Latin America and the Middle East & Africa, the market is developing steadily as healthcare systems evolve and scientific research capabilities continue to improve. Further, rising capital funding for biomedical research, greater focus on healthcare innovation, and expanding participation in international research collaborations are fueling the need for drug discovery technologies.

Mexico Drug Discovery Technologies Market- Key Insights

Mexico is gaining major attention in the drug discovery technologies market as its pharmaceutical industry continues to expand and investments in biomedical research increase. Stronger collaboration between local organizations and global life sciences companies is helping strengthen the country's research capabilities and support the development of innovative therapies. a growing number of biotechnology startups are contributing to the advancement of drug discovery by adopting modern tools such as computational biology, molecular simulation, and data-driven research platforms. These technologies enable researchers to identify promising drug candidates more efficiently and accelerate early-stage development activities. Thus, improving research productivity will increase the adoption of advanced drug discovery solutions.

Drug Discovery Technologies Market- Competitive Landscape:

The drug discovery technologies market is formulated by intense competition as technology providers, pharmaceutical companies, and biotechnology firms emphasize on novel drug development. Companies are developing platforms that can analyze complex biological and chemical datasets, and support faster decision-making during early-stage research. Additionally, advances in genomics, and multi-omics research are encouraging companies to improve their discovery platforms with more sophisticated analytical capabilities. Thus, expanding research, new drug discovery is shaping the competitive landscape of the drug discovery technologies market.

Recent Developments:

In January 2025, Owkin launched Owkin K1.0 Turbigo, an AI-enabled platform developed to enhance drug discovery, therapeutic development, and diagnostic research. The solution combines advanced artificial intelligence models with intelligent digital agents to generate biological insights, streamline research workflows, and support more efficient decision-making.

In January 2025, Absci and Owkin formed a strategic collaboration to bolster AI-driven drug discovery capabilities. The partnership combines Owkin's artificial intelligence-based target identification expertise with Absci's generative AI technology for biologics design.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • Danaher Corporation
  • Agilent Technologies
  • PerkinElmer
  • Bio-Rad Laboratories
  • Illumina
  • Waters Corporation
  • Bruker Corporation
  • Charles River Laboratories
  • Evotec SE
  • Schrodinger
  • Certara
  • IQVIA
  • Benchling
  • Recursion Pharmaceuticals
  • Owkin
  • Others

GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2020-2033

  • Biologics
  • Small molecule drugs
  • Cell & gene therapies
  • Vaccines
  • Protein & peptide drugs
  • Others

GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020-2033

  • High-Throughput Screening (HTS)
  • Genomics and Proteomics Technologies
  • Combinatorial Chemistry
  • Computational Drug Discovery
  • Pharmacogenomics
  • Others

GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

  • Neurology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Immunology and Autoimmune Disorders
  • Oncology
  • Others

GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

  • Pharmaceutical & Biotech Companies
  • Contract Research Organizations (CROs)
  • Academic Research
  • Others

GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Drug Discovery Technologies Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Drug Discovery Technologies Market Snippet by Drug Type
    • 2.1.2. Drug Discovery Technologies Market Snippet by Technology
    • 2.1.3. Drug Discovery Technologies Market Snippet by Application
    • 2.1.4. Drug Discovery Technologies Market Snippet by End-Use
    • 2.1.5. Drug Discovery Technologies Market Snippet by Country
    • 2.1.6. Drug Discovery Technologies Market Snippet by Region
  • 2.2. Competitive Insights

3. Drug Discovery Technologies Key Market Trends

  • 3.1. Drug Discovery Technologies Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Drug Discovery Technologies Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Drug Discovery Technologies Market Opportunities
  • 3.4. Drug Discovery Technologies Market Future Trends

4. Drug Discovery Technologies Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Drug Discovery Technologies Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Drug Discovery Technologies Market Landscape

  • 6.1. Drug Discovery Technologies Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Drug Discovery Technologies Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2025 & 2033 (%)
    • 7.1.2. Biologics
    • 7.1.3. Small molecule drugs
    • 7.1.4. Cell & gene therapies
    • 7.1.5. Vaccines
    • 7.1.6. Protein & peptide drugs
    • 7.1.7. Others

8. Drug Discovery Technologies Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 8.1.2. High-Throughput Screening (HTS)
    • 8.1.3. Genomics and Proteomics Technologies
    • 8.1.4. Combinatorial Chemistry
    • 8.1.5. Computational Drug Discovery
    • 8.1.6. Pharmacogenomics
    • 8.1.7. Others

9. Drug Discovery Technologies Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 9.1.2. Neurology
    • 9.1.3. Cardiovascular Diseases
    • 9.1.4. Infectious Diseases
    • 9.1.5. Immunology and Autoimmune Disorders
    • 9.1.6. Oncology
    • 9.1.7. Others

10. Drug Discovery Technologies Market - By End-Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
    • 10.1.2. Pharmaceutical & Biotech Companies
    • 10.1.3. Contract Research Organizations (CROs)
    • 10.1.4. Academic Research
    • 10.1.5. Others

11. Drug Discovery Technologies Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Drug Discovery Technologies Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Drug Discovery Technologies Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Drug Discovery Technologies Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Drug Discovery Technologies Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Drug Discovery Technologies Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Drug Discovery Technologies Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific
    • 12.2.2. Danaher Corporation
    • 12.2.3. Agilent Technologies
    • 12.2.4. PerkinElmer
    • 12.2.5. Bio-Rad Laboratories
    • 12.2.6. Illumina
    • 12.2.7. Waters Corporation
    • 12.2.8. Bruker Corporation
    • 12.2.9. Charles River Laboratories
    • 12.2.10. Evotec SE
    • 12.2.11. Schrodinger
    • 12.2.12. Certara
    • 12.2.13. IQVIA
    • 12.2.14. Benchling
    • 12.2.15. Recursion Pharmaceuticals
    • 12.2.16. Owkin
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us